Your session is about to expire
← Back to Search
Exercise for Enhancing COVID-19 Immunization
Study Summary
This trial is investigating whether a single session of exercise shortly after receiving the third dose of the COVID-19 vaccine may improve the immune response to vaccination, and identify potential mechanisms behind this using gene expression and metabolite analysis.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I can give a small blood sample.I am on medication that affects my immune system or have an immune disorder.I have no health issues preventing me from exercising safely or getting the mRNA COVID-19 vaccine.I weigh less than 110 pounds.I plan to get my first mRNA COVID-19 vaccine.I am between 18 and 64 years old.
- Group 1: Exercise post-immunization
- Group 2: Daily routine as usual (control)
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is the current research initiative open to elderly individuals?
"As outlined in the study's terms of admission, individuals who are 18 years old and above but below 70 can be considered for enrolment."
Are there any opportunities to partake in this experiment currently?
"Clinicaltrials.gov currently displays that this medical trial is proactively recruiting participants, with the first post being dated October 15th 2021 and last updated on January 24th 2022."
What are the prerequisites for joining this clinical experiment?
"This medical trial is recruiting 130 individuals with immunizations who are aged between 18 and 70. Further, suitable candidates must be willing to donate blood samples, intend to receive an mRNA-based Severe Acute Respiratory Distress Syndrome Coronavirus 2 vaccine booster dose, partake in physical activity regularly (e.g., walking/jogging for 90 minutes per American College of Sports Medicine guidelines), and demonstrate that they can perform light-to-moderate intensity exercises safely."
How many participants have been selected to join this research endeavor?
"Indeed, the information on clinicaltrials.gov confirms that this research is actively recruiting participants. The trial was originally posted to the website in October of 2021 and last modified in January 2022; it seeks 130 people from a single site."
Share this study with friends
Copy Link
Messenger